KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Depreciation and Depletion: 2009-2010

Historic Depreciation and Depletion for Novavax (NVAX) over the last 2 years, with Dec 2010 value amounting to $2.67.

  • Novavax's Depreciation and Depletion fell 39.46% to $2.67 in Q4 2010 from the same period last year, while for Dec 2010 it was $11.00, marking a year-over-year decrease of 100.00%. This contributed to the annual value of $200,000 for FY2013, which is N/A change from last year.
  • Per Novavax's latest filing, its Depreciation and Depletion stood at $2.67 for Q4 2010, which was up 14.10% from $2.34 recorded in Q3 2010.
  • Novavax's Depreciation and Depletion's 5-year high stood at $15.0 billion during Q2 2009, with a 5-year trough of -$15.0 billion in Q3 2009.
  • In the last 2 years, Novavax's Depreciation and Depletion had a median value of $3.00 in 2010 and averaged $112,377.
  • Over the last 5 years, Novavax's Depreciation and Depletion had its largest YoY gain of 100.00% in 2010, and its largest YoY loss of 100.00% in 2010.
  • Over the past 2 years, Novavax's Depreciation and Depletion (Quarterly) stood at $4.41 in 2009, then crashed by 39.46% to $2.67 in 2010.
  • Its Depreciation and Depletion was $2.67 in Q4 2010, compared to $2.34 in Q3 2010 and $2.97 in Q2 2010.